Does this help? From the FDA SSED, June 2021 expanded use approval
Results from the retrospective study provide sufficient initial evidence to support a 6-month shelf life for the RECELL® Device (based on available stability data provided for the activity of the Enzyme component). A prospective study assessing Enzyme stability will be performed to support future extension of the current 18-month shelf-life.
Ann: Quarterly Financial Report (Form 10-Q), page-43
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.63 |
Change
0.160(6.48%) |
Mkt cap ! $179.0M | |||
| Open | High | Low | Value | Volume |
| $2.54 | $2.64 | $2.54 | $874.2K | 336.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3056 | $2.62 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.63 | 4999 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| AVH (ASX) Chart |